The distant recurrence of HCC decreased in the group receiving IFN (22%) as compared to the group that did not receive IFN (82%) and was, thus, highly significant. 14 Also, Arnaoutakis et al revealed that the incidence of HCC decreased significantly in cases with SVR after IFN therapy compared to non-IFN group (48 vs 70%, respectively). 7 Similar findings were confirmed by Naoya et al and Cheol et al who reported that the recurrence of HCC decreased signific
← all excerpts
Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves.
1
—
—